Figure S16 from Discovery of Targets for Immune–Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha

Avinash Sahu(New Mexico Department of Health), Keith T. Flaherty(Cancer Research Center), Joost A.P. Rens(Erasmus MC), Xiaoman Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Meriem Bourajjaj(Pharmaleads (France)), Collin Tokheim(Johns Hopkins University), Clifford A. Meyer(Dana-Farber Cancer Institute), Shengqing Gu(Dana-Farber Cancer Institute), Phillip Nicol(Harvard University Press), Phillip Munson(University of Vermont), Nishanth Ulhas Nair(National Cancer Institute), Ya Han(Tongji University), Inge Leenders(Pharmaleads (France)), Wubing Zhang(California Institute for Regenerative Medicine), X. Shirley Liu(Harbin Medical University), Jin Wang(Dana-Farber Cancer Institute), Laura van Zelst(Pharmaleads (France)), Bas Jansen(Radboud University Nijmegen), Jan P.G. Klomp, Arthur Oubrie(Pharmaleads (France)), Jingxin Fu(Tongji University), Chenfei Wang(Tongji University), Jenny Worthington(Fisher Bioservices (United States)), Gege Qian(University of California San Diego), Jaap Lemmers(Pharmaleads (France)), David E. Fisher(Massachusetts General Hospital), Zexian Zeng(Peking University), Mark Musters(Pharmaleads (France)), Dejan Juric(Massachusetts General Hospital), Sanne van Zanten(Pharmaleads (France)), Xiaoqing Wang(Roche (China)), Jun S. Liu(Hubei University of Arts and Science)
Unknown
April 4, 2023
Cited by 0


Related Papers